Objectives/Hypothesis: High-resolution optical imaging is an imaging modality that allows visualization of structural changes in epithelial tissue in real time. Our prior studies using contrast-enhanced microendoscopy to image squamous cell carcinoma in the head and neck demonstrated that the contrast agent, proflavine, has high affinity for keratinized tissue. Thus, high-resolution microendoscopy with proflavine provides a potential mechanism to identify ectopic keratin production, such as that associated with cholesteatoma formation, and distinguish between uninvolved mucosa and residual keratin at the time of surgery.
INTRODUCTION
Cholesteatomas are sacs of keratinizing squamous epithelium that can occur in the middle ear and mastoid. Cholesteatomas can enlarge, become infected, and cause local destruction through bony erosion. The only available treatment for this disease is complete surgical resection via tympanomastoidectomy. 1 However, surgical treatment is not always curative because regrowth of disease (recidivism) is relatively common even in experienced hands, with rates ranging from 5% to 50% in published series. [2] [3] [4] Revision surgery is mandatory in these cases, but this subjects the patient to a second operation and does not fully assure against further recurrences. Cholesteatoma recidivism occurs by two different mechanisms: recurrence is the reformation of an epithelial sac because eustachian tube dysfunction allows a new retraction pocket to develop, and residual cholesteatoma is disease left behind by the surgeon that persists and later regrows. The rate of residual disease has been reported as high as 30% in some published series. 4 Thus, it is critical to completely remove all microscopic disease at the initial surgery. To date, there is no well-established intraoperative imaging device or technique that can prevent residual disease.
Histologically, cholesteatoma is distinct from the simple cuboidal or ciliated columnar epithelium lining the middle ear and mastoid air cells. Cholesteatoma is comprised of keratinizing squamous epithelium and has four layers, the same as in skin epidermis, which include the basal, squamous, granulosum, and stratum corneum, and which are supported underneath by loose connective tissue. 5, 6 These lesions, like skin, shed keratin debris and stain positive for cytokeratins. [7] [8] [9] From the Department of Otolaryngology-Head and Neck Surgery (L.L.L., N.J., E.S., A.G.S.) and Tisch Cancer Institute (R.R. Optical imaging technologies provide noninvasive visualization of tissue epithelium in real time.
10-12 A novel endoscopic technique using high-resolution microendoscopy (HRME) allows for the spatial resolution of individual nuclei and cellular structures. 13 The potential applications of this approach are broad, including the detection of neoplastic changes in the mucosa of the head and neck and esophagus. 14, 15 Our previous studies using this device to image squamous cell carcinomas in the head and neck have demonstrated that keratinized tissue has a high affinity for the contrast agent proflavine, thus providing a mechanism to potentially identify and differentiate cholesteatoma from the surrounding middle ear epithelium. 15, 16 In this article, we describe the use of contrastenhanced HRME for the detection of cholesteatoma in the middle ear. The flexible fiberoptic microscope provides a mechanism to obtain real-time intraoperative images of tissue epithelium, and is a promising approach to discriminate between cholesteatoma and surrounding normal mucosa at the point of care.
MATERIALS AND METHODS

Imaging System
The HRME has been previously described. 13 Briefly, the system consists of a fiberoptic probe, an LED (light-emitting diode) light source, and a CCD (charge-coupled device) camera connected to a laptop computer for image capture and storage (Fig. 1A,B) . The fiberoptic probe tip is small and flexible, allowing for access to the middle ear space (Fig. 1C) . This imaging platform is designed for use with proflavine (Sigma-Aldrich, St. Louis, MO), a fluorescent contrast agent from the acriflavine family that reversibly binds to DNA and stains cell nuclei. 17 Proflavine is buffered with saline to 0.01% solution, and a small amount is applied topically to tissue epithelium with a cottontipped applicator. Proflavine has been used in in vivo studies of the gastrointestinal tract in Europe and Australia without any reported adverse events, and is a component of the dye used to prevent infection of the umbilical stump of newborns. [18] [19] [20] Proflavine has never been applied to the middle ear; thus, the ototoxicity of this agent is currently unknown. Future clinical studies are therefore required to determine the safety profile for use in the middle ear.
Specimen Acquisition and Imaging
Through a study protocol approved by the Mount Sinai School of Medicine Institutional Review Board (GCO# 11-1262), we obtained seven anonymized surgical specimens of cholesteatoma, which had been stored at À80 C for 1 to 2 years prior to this study. Specimens were thawed to room temperature prior to application of proflavine solution (0.01% in saline) to the specimen with a cotton-tipped applicator and subsequent imaging with the fiberoptic probe (Fig. 1D) . The specimens were then sent for histological processing and preparation of Images of the gingiva and head and neck squamous cell carcinoma specimens were obtained through a study protocol approved by the Mount Sinai School of Medicine Institutional Review Board (GCO 09-0954). Grossly normal and malignant areas of the fresh tumor specimen were stained immediately with proflavine following standard-of-care surgical resection. After topical application of the dye, the fiberoptic probe was used to view these areas and capture images or movie clips of 3-seconds duration. Movie clips were converted to still images using Windows Movie Maker (Microsoft, Redmond, WA). A 3-mm punch biopsy of the imaged site was analyzed by conventional H&E histopathology by a board-certified pathologist.
RESULTS
We could successfully image cholesteatoma and uninvolved mucosa from all seven specimens. Contrastenhanced images of cholesteatoma specimens appeared as areas of confluent hyperfluorescence that correlated to histologically confirmed keratin (Fig. 2) . The high-resolution images of cholesteatoma, composed of mostly keratin, appeared similar to images from areas of keratinized epithelium in the upper aerodigestive tract (Fig. 3) . Images of middle ear epithelium surrounding the cholesteatoma displayed obvious normal-appearing nuclei, which correlated with corresponding histology (Fig. 4) . Therefore, hyperfluorescence and loss of cellular architecture are the microendoscopic imaging hallmarks of cholesteatomas due to high keratin composition. The striking affinity of proflavine for keratin allows straightforward differentiation from surrounding middle ear epithelium, in which nuclei are readily visualized.
DISCUSSION
Here we describe the first report of an optical imaging device applied to otologic surgery. The differences between cholesteatoma and middle ear epithelium are readily apparent in the proflavine-enhanced images, providing a mechanism to ensure elimination of all diseased tissue. These results support future in vivo intraoperative application of HRME, as the fiberoptic endoscope can readily be applied during mastoid procedures and provide real-time imaging that can assist the otologic surgeon.
The treatment of cholesteatoma is thwarted by the tendency of the disease to regrow, even after adequate surgical removal in the most experienced hands. Cholesteatoma regrowth can be the result of disease recurrence (the formation of a new sac by invasion of skin from the external canal into the middle ear), or residual cholesteatoma (disease unknowingly left behind by the surgeon). 21, 22 Cholesteatoma recurrences are associated with increased morbidity, including the need for additional surgery, further loss of hearing, recurrent infection, and potential complications including labyrinthitis and intracranial spread. 23 Therefore, a mechanism that could identify residual disease intraoperatively would be a worthwhile advance in the treatment of this aggressive disease to reduce the chance of residual disease.
In our prior studies utilizing HRME for imaging head and neck squamous cell carcinomas, keratinizing epithelium appeared hyperfluorescent, which obstructed visualization of nuclei and was a limitation in Fig. 3 . Appearance of keratin imaged with contrast-enhanced HRME. HRME image (left) of histologically (H&E, original magnification 100Â) confirmed (right) keratin from the gingiva of a composite resection of the oral cavity. The arrow indicates a layer of superficial keratin.
Notice that the HRME image shows hyperfluorescence without discrete visualization of nuclei. distinguishing benign from cancerous mucosa. Keratin absorbs proflavine; thus, these contrast-enhanced images appear as hyperfluorescent. Proflavine, a member of the acridine family, is positively charged, and thus intercalates between negatively charged double-stranded DNA in a noncovalent manner. 24 Although the precise mechanism of proflavine's affinity for keratin is not understood, it may in part be a result of the overall negative charge of keratin molecules. 25, 26 Although hyperkeratosis presents an obstacle to detecting squamous cell carcinoma of the upper aerodigestive tract, for cholesteatoma, keratin provides the key diagnostic imaging hallmark in HRME images. This is the first report utilizing the HRME in combination with proflavine on samples that were frozen for an extended period of time. In our prior head and neck studies, ex vivo imaging was performed on fresh specimens immediately following surgical resection. 13, 14, 16 Although we have not done a controlled comparison, in general, we observe that in vivo images show higher contrast than ex vivo images of fresh or frozen/thawed tissue. We speculate that the reduction in contrast is due to partial autolysis that occurs in the ex vivo specimens, resulting in additional cytoplasmic staining. Nonetheless, the image features otherwise appear quite similar in the ex vivo and in vivo images despite the temperature differences. This is true across a wide variety of organ sites, including oral cavity, breast, uterine cervix, and esophagus, for which our group has performed both published and ongoing in vivo studies.
In addition to the obvious application of the HRME to direct in vivo imaging of cholesteatomas to aid in surgical removal, the highly keratinized cholesteatoma specimens can serve as a platform for further investigations of the unique imaging properties of keratin, including its interactions with proflavine, and potentially, other contrast agents. A better understanding of the imaging properties of keratin and its associated hyperfluorescence and obstruction of nuclear detail would improve the utility of HRME for cancer detection in the upper aerodigestive tract, and potentially allow application of contrast-enhanced HRME to other highly keratinized organ systems such as skin.
CONCLUSION
This ex vivo study demonstrates the feasibility of proflavine-enhanced HRME to distinguish cholesteatoma from uninvolved middle ear mucosa. Further in vivo studies are required to test the hypothesis that intraoperative real-time imaging can enhance surgical removal by identifying residual disease, and thereby improve patient prognosis and surgical outcome. 
